Abstract
We report a case of a 15-month-old Japanese girl with Kawasaki disease (KD) associated with bacteremia caused by Streptococcus pneumoniae (S. pneumoniae) 12F (a nonvaccine serotype). The patient had completed the pneumococcal 13-valent conjugate vaccination according to the immunization schedule for children in Japan. She presented at the emergency department of our hospital with fever for 3 days and all other KD symptoms and was admitted. Despite the detection of S. pneumoniae 12F in the blood culture on admission, initial treatment for KD with 2 g/kg of intravenous immunoglobulin and 30 mg/kg/day of oral aspirin without antibiotic administration improved both KD symptoms and bacteremia. The patient did not develop coronary aneurysm. Even though there were no reports of KD with bacteremia caused by S. pneumoniae (except in our case), the presence of bacteremia may not affect the treatment response or coronary artery outcome if KD is appropriately treated.
Similar content being viewed by others
References
Kawasaki T, Kosaki F, Okawa S, Shigematsu I, Yanagawa H. A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan. Pediatrics. 1974;54:271–6.
McCrindle BW, Rowley AH, Newburger JW, Burns JC, Bolger AF, Gewitz M, Baker AL, Jackson MA, Takahashi M, Shah PB, Kobayashi T, Wu MH, Saji TT, Pahl E; American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; Council on Cardiovascular Surgery and Anesthesia; and Council on Epidemiology and Prevention. Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association. Circulation. 2017;25:135:e927–99.
Huang SM, Huang SH, Weng KP, Chien KJ, Lin CC, Huang YF. Update on association between Kawasaki disease and infection. J Chin Med Assoc. 2019;82:172–4.
Lee Y, Wakita D, Dagvadorj J, Shimada K, Chen S, Huang G, et al. IL-1 signaling is critically required in stromal cells in Kawasaki disease vasculitis mouse model role of both IL-1α and IL-1β. Arterioscler Thromb Vasc Biol. 2015;35:2605–16.
Alphonse MP, Duong TT, Shumitzu C, Hoang TL, McCrindle BW, Franco A, et al. J Immunol. 2016;197:3481–9.
Lapointe N, Chad Z, Lacroix J, Jacob JL, Urbanski P, Polomeno R, et al. Kawasaki disease: association with uveitis in seven patient. Pediatrics. 1982;69:376–8.
Johnson D, Azimi P. Kawasaki disease associated with Klebsiella pneumoniae bacteremia and parainfluenza type 3 virus infection. Pediatr Infect Dis. 1985;4:100.
Tsurumizu T, Okonogi H, Shibusawa T, Hashimoto T, Makino M, Ota H, et al. A case of Kawasaki’s disease combined with septicemia isolation of Streptococcus sanguis (MCLS-1) and Streptococcus pyogenes from blood at the acute stage. Kansenshogaku Zasshi. 1991;65:124–8.
Hall M, Hoyt L, Ferrieri P, Schlievert PM, Jenson HB. Kawasaki syndrome-like illness associated with infection caused by enterotoxin B-secreting Staphylococcus aureus. Clin Infect Dis. 1999;29:586–9.
Benseler SM, McCrindle BW, Silverman ED, Tyrrell PN, Wong J, Yeung RS. Infections and Kawasaki disease: implications for coronary artery outcome. Pediatrics. 2005;116:e760–6.
Iaria C, Stassi G, Salpietro DC, La Mazza A, Silipigni L, Arena A, et al. Clostridium baratii bacteremia associated with Kawasaki syndrome. First case report. New Microbiol. 2007;30:481–4.
Baraff LJ, Bass JW, Fleisher GR, Klein JO, McCracken GH Jr, Powell KR, et al. Practice guideline for the management of infants and children 0 to 36 months of age with fever without source. Agency for Health Care Policy and Research. Ann Emerg Med. 1993;22:1198–210.
Korones DN, Shapiro ED. Occult pneumococcal bacteremia: what happens to the child who appears well at reevaluation? Pediatr Infect Dis J. 1994;13:382–6.
Knutsen AP, Leiva LE, Caruthers C, Rodrigues J, Sorensen RU. Streptococcus pneumoniae antibody titres in patients with primary antibody deficiency receiving intravenous immunoglobulin (IVIG) compared to subcutaneous immunoglobulin (SCIG). Clin Exp Immunol. 2015;182:51–6.
Acknowledgments
We are grateful for technical assistance for analyzing the serotype of Streptococcus pneumoniae at Yokohama City Institute of Health.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no conflict of interest.
Ethical Approval
All applicable international, national, and/or institutional guidelines for the care were followed. Informed consent was obtained from the patient’s parents under ethical approval (The Ethics Committee of Showa University School of Medicine, No. 19 T7021).
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article is part of the Topical Collection on Medicine
Rights and permissions
About this article
Cite this article
Watanabe, Y., Honda, K., Abe, Y. et al. Kawasaki Disease Associated with Pneumococcal Infection. SN Compr. Clin. Med. 2, 108–110 (2020). https://doi.org/10.1007/s42399-019-00196-w
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s42399-019-00196-w